Skip to main content

Table 2 Diabetes Complications per treatment strategy at current period

From: A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies

Complication n (%)

Total

Treatment Strategy

P

A

B

C

Acute complications

15 (3.7%)

2 (0.5%)

1 (0.2%)

12 (2.9%)

NA

Non-ketotic Hyperglycaemic Hyperosmolar Coma

2 (0.2%)

1 (0.4%)

0 (0%)

1 (0.2%)

NA

Infections

2 (0.2%)

0 (0%)

0 (0%)

2 (0.4%)

NA

Diabetes-associated Hospitalisation

3 (0.3%)

0 (0%)

0 (0%)

3 (0,6%)

NA

Other

7 (0.6%)

1 (0.4%)

1 (0.2%)

5 (1.1%)

NA

Chronic complications

386 (32.5%)

29 (12.0%)

130 (27.2%)

227 (48.3%)

 

Diabetic Retinopathy

141 (11.9%)

6 (2.5%)

36 (7.5%)

99 (21.1%)

< 0.001

Diabetic Nephropathy

140 (11.8%)

16 (6.6%)

43 (9.0%)

81 (17.2%)

< 0.001

Diabetic Neuropathy

136 (11.4%)

7 (2.9%)

33 (6.9%)

96 (20.4%)

< 0.001

Diabetic Foot: ulcers

14 (1.2%)

1 (0.4%)

6 (1.3%)

7 (1.5%)

NA

Diabetic Foot: extensive superficial lesions

7 (0.6%)

1 (0.4%)

3 (0.6%)

3 (0.6%)

NA

Diabetic Foot: gangrene

2 (0.2%)

0 (0%)

0 (0%)

2 (0.4%)

NA

Diabetic Foot: lower extremity amputation

3 (0.3%)

0 (0%)

0 (0%)

3 (0.6%)

NA

Cardiovascular events

69 (5.8%)

4 (1.7%)

29 (6.1%)

36 (7.7%)

0.005

Carotid Artery Disease

24 (2.0%)

3 (1.2%)

2 (0.4%)

19 (4.0%)

< 0.001

Peripheral Arterial Disease

48 (4%)

3 (1.2%)

12 (2.5%)

33 (7%)

< 0.001

Other

23 (1.9%)

2 (0.8%)

7 (1.5%)

14 (3%)

0.09